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Summary The chemical carcinogen 7,12-dimethylbenz (a) anthracene (DMBA) is a potent carcinogen which,
when applied to the skin of BALB/c mice weekly for 7-8 weeks, causes the induction of macroscopically
visible skin tumours. We report that DMBA also depletes Langerhans cells (LC) from treated skin; the
number of cutaneous LC is reduced by nearly 50% 3 days after the first application of DMBA, and continues
to decrease upon further treatment. After 7-8 weeks of DMBA application, while tumours are becoming
macroscopically visible, there is a considerably lower LC density in treated skin. Upon cessation of the
DMBA treatment, the LC repopulate the skin, returning to control values within 55-64 days. During this
repopulation of the skin by LC, the tumours begin to decrease in size. Since LC function as local cutaneous
antigen-presenting cells, and are responsible for initiation of an immune response against antigens in the skin,
their depletion during tumour induction may allow DMBA-transformed cells to circumvent the immune
system and form tumours. Their reappearance associated with tumour regression suggests that the LC are
involved in an immune response against the tumours.
Langerhans cells (LC) are the initial cells involved
in a local immune response against antigens in the
skin, where they function as antigen-presenting cells
(Halliday & Muller, 1984). They are bone marrow
derived dendritic cells (Stingl et al., 1980) which
bind antigen (Shelley & Juhlin, 1976) and transport
it to the local lymph nodes (Silberberg-Sinakin et
al., 1977) for presentation to T cells, resulting in a
specific immune response against the antigen.
LC have been shown to be necessary for
initiation of immune responses both in vivo and in
vitro. In vivo studies of mouse skin depleted of LC
by ultraviolet (UV) light irradiation have shown
that LC are necessary for the induction of contact
sensitivity (Toews et al., 1980). In these experiments
skin depleted of LC by UV-light could not support
initiation of contact sensitivity, although contact
sensitivity could be initiated via untreated skin.
Thus local depletion of LC abolished the potential
for an immune response against antigens in that
locality, while a normal immune response could be
initiated against antigens in other sites. In vitro
studies using monocyte-depleted lymphocytes
cultured with epidermal LC and antigen have
formally proven that LC are able to present antigen
to lymphocytes, initiating a specific immune
response (Stingl et al., 1978; Braathen & Thorsby,
1983).
Since LC are essential for an immune response to
develop against antigens in the skin, the possible
role of LC in the initiation of an immune response
against cutaneous neoplastic cells is of considerable
importance. We therefore investigated the effects of
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the chemical carcinogen 7,12-dimethylbenz (a)
anthracene (DMBA) on LC numbers and
morphology as assessed by adenosine triphos-
phatase (ATPase) staining during the induction and
growth of DMBA-induced skin tumours. DMBA
caused depletion of LC from skin surrounding the
tumours, and the LC reappeared as the tumours
ceased growing. The time scale of reappearance of
LC suggests they were being repopulated from
bone-marrow derived precursors.
Materials and methods
Carcinogen treatment ofmice
Male BALB/c mice were obtained from Walter and
Eliza Hall Institute, Melbourne; from 8-9 weeks of
age they were treated with 7,12-dimethylbenz (a)
anthracene (DMBA, Sigma, USA, Lot 24F-0052) as
described by Muller & Flannery (1973). The dorsal
trunk skin of the mice was shaved with electric
clippers and painted with 1% DMBA dissolved in
equal volumes of lanoline (Sigma, USA) and liquid
paraffin (Supply and Tender, Hobart); control mice
received solvent alone.
To determine the early effects of DMBA on LC
before tumours became apparent, groups of 4 mice
were treated with DMBA. The first application of
DMBA was designated as being on day 0, with
weekly applications for up to 4 weeks; mice being
killed 3 or 7 days following the last treatment. To
determine the LC density in DMBA-treated skin
during growth of DMBA-induced tumours, the
DMBA was applied weekly for 7-8 weeks, the final
application of DMBA was designated as being on
day 0.
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Preparation ofepidermal sheets
At various times after the final application of
DMBA, non-tumour bearing DMBA-painted skin
was removed for assessment of LC numbers. At
least one control mouse was included with each
group of DMBA-treated mice. Skin was removed
from the same site for control and test mice. The
mice were killed by cervical dislocation, and prior
to surgical removal the dorsal trunk skin was
shaved, depilated (Veet, Reckitt & Colman Ltd.,
UK), and rinsed of depilant with tap water.
Epidermal sheets were prepared by a method
modified from that of Baker & Habowsky (1983).
The skin was divided into 5mm squares using a
perspex template and subcutaneous fat was
removed. The skin was incubated overnight at
room temperature in PBS (pH 7.3) containing
20mM ethylenediaminetetraacetic acid (EDTA) and
0.001% trypsin (Boehringer, W. Germany, Lot
1313157). Following incubation, the skin was
submerged in PBS containing 1 mM MgCl2
(PBS/Mg 5), and the stratum corneum and dermal
layers were gently removed from the epidermis
using fine forceps and a dissecting microscope.
ATPase staining ofLC
Epidermal sheets were stained for the enzyme
adenosine triphosphatase (ATPase) by a method
adapted from those of Baker & Habowsky (1983)
and Daniels (1984). Epidermal sheets were washed
in PBS/Mg+ +; fixed in cacodylate-buffered 2%
formaldehyde (pH 7.3) for 20min at 4°C; washed
with 3 changes of saline over Omin; stained for 1 h
at 37°C with 21 mM trizma-maleate buffer (pH 7.3,
Sigma, USA, Lot 61C-5130) containing 0.36mM
disodium adenosine triphosphate (ATP, vanadium
free, Sigma, USA, Lot 91F-7165), 10.37mM
MgSO4, 2.2mM Pb(NO03)2, and 0.25M sucrose;
washed with 2 changes of saline over 5min;
developed with 2 drops of 20% ammonium sulfide
in 50ml distilled water for 5min at room
temperature; and washed with 2 changes of saline
over 5min. The sheets were then counterstained
with 2% methyl green (Schmid and Co., W.
Germany, Lot 11105) in distilled water for 5min,
washed with 3 changes of saline over Omin, and
mounted on glass slides, with the dermal surface
down, in glycerin: PBS (9:1, v:v).
Enumeration ofLC in epidermal sheets
For each mouse the number of LC in the dorsal
trunk skin were enumerated microscopically in 4
replicate epidermal sheets, the total area being
2.5mm2. To correct for stretching during
preparation the area of each sheet was measured
using a Bioquant II basic measuring program
volume 185 (r & m biometrics, USA) for an Apple
Ile computer.
Histological identification oftumours
DMBA-induced tumours were surgically excised,
fixed overnight in 10% formalin in PBS (pH 7.3),
and vacuum embedded in wax. Vertical sections
were stained with haematoxylin and eosin for histo-
logical examination.
Statistical analysis
LC densities from DMBA-treated and control mice
were compared using an unpaired Wilcoxon ranked
sum test.
Results
Effect ofDMBA treatment on LC density
The early effects of DMBA treatment on LC
density in mouse skin are shown in Figure 1.
Control mice had a mean LC density of 420mm2,
while 3 days after the first application of DMBA
this was significantly reduced to 226mm 2
(P<0.05). The number of LC continued to
decrease, and by 7 days following the first
application of DMBA was 189mm2, which is
significantly lower than the control values
(P<0.05). Subsequent applications of DMBA
further decreased the LC densities to 118 mm2 7
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Figure 1 Langerhans cell numbers in mouse skin
following weekly treatments with DMBA. Control
mice were treated with solvent alone. Each point
represents the average count of 4 replicate epidermal
sheets from one mouse.
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days after 2 weekly applications; 97Mmm2 7 days
after 3 weekly applications, and 71mm-2 7 days
after 4 weekly applications, all of which are
significantly lower than the control values
(P<0.05). Following 8 weekly applications of
DMBA no detectable LC were observed in 2 mice
(Figure 2).
LC density during growth ofDMBA-induced
tumours
LC densities at various times following cessation of
7-8 weekly applications of DMBA are shown in
Figure 2, the means for 10 day periods are shown
in Table I. Tumours were becoming visible macro-
scopically during this time period (Table I). All
cutaneous lesions had appeared by day 24, with an
average of 3 per mouse and a range of 1 to 8. The
tumours showed a spectrum of disordered cell
growth ranging from squamous papillomas and
keratoacanthomas to a few squamous cell
carcinomas. The remainder of the lesions were
identified as squamous keratoses. The tumours
commenced to reduce in size by day 25, with 48%
regressing by days 55-64 (Table I), indicating
reduced tumour growth with time.
During the first 14 days following the last
application of DMBA the number of LC was
depleted by -75%, and during this time 94% of
the tumours became macroscopically visible. The
LC density then linearly increased towards control
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Table I Tumour growth pattern and Langerhans cell
numbers in mouse skin painted weekly with DMBA for
7-8 weeks
Timeperiod Percentage
since last Percentage oftotal Mean
application oftotal tumours number of
ofDMBA tumours decreasing Langerhans
(days) induced in size cells mm 2
0-4 53 0 n.d.
5-14 41 0 101 (n=4)a
15-24 6 0 n.d.
25-34 0 7 339 (n=6)'
35-44 0 28 223 (n=4)a
45-54 0 44 332 (n=4)a
55-64 0 48 385 (n=4)b
Control micec 425 (n= 10)
n=number of mice.
n.d. =not done.
aSignificance of difference
(Wilcoxon rank sum test).
from control P<0.05
bNot significantly different from control (Wilcoxon rank
sum test).
cControl mice were painted with solvent alone.
values, remaining significantly depleted even at 45-
54 days, but returning to control values by 55-64
days following the DMBA treatment. As the LC
returned to control values the tumours stopped
growing and began to decrease in size. The LC
which initially reappeared in the epidermis had short,
thickened dendrites; after 30-40 days typical inter-
digitating LC were present with similar morphology
to control LC.
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Figure 2 Langerhans cell numbers in mouse skin
which had been painted weekly with DMBA or solvent
(control) for 7-8 weeks; the final application was
designated Day 0. Each point represents the average
count of 4 replicate epidermal sheets from one mouse.
We have shown that the chemical carcinogen
DMBA causes a rapid depletion of the local
antigen-presenting LC during tumour induction,
and that these cells reappear as the tumours stop
growing and commence to decrease in size. This
suggests that in the skin, the LC may have a role in
protection against skin tumours, and that a defect
in local antigen presentation may be required for a
transformed cell to escape the immune system and
multiply into a tumour.
LC were identified in epidermal sheets by
staining for the plasma membrane bound enzyme
ATPase which in the epidermis specifically stains
LC (Rowden, 1981). Epidermal sheets were
prepared by modification of a procedure which
used incubation in EDTA at 37°C for 2.5h to
enable separation of dermis from epidermis (Baker
& Habowsky, 1983). We found that inclusion of
.
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low concentration trypsin (0.001%), and incubation
at room temperature overnight improved the LC
morphology and ATPase staining, producing
epidermal sheets in which the LC were observed to
link with each other via their dendrites, allowing
them to be more accurately quantitated. Using this
procedure control BALB/c mice were found to have
LC densities ranging from 340 to 690mm 2.
Although other mouse strains have been reported
with higher dorsal trunk epidermal LC densities e.g.
760 mm 2 for C57BL mice and 880 mm-2 for
A/Jax mice (Bergstresser et al., 1980), reported
mean LC densities in normal epidermis vary
considerably; in the case of human anterior forearm
skin from 458mm 2 (Berman et al., 1983) to
720mm-2 (Friedmann, 1981).
It is possible that identification of LC by the
surface membrane component ATPase may detect
modulation of the enzyme rather than
disappearance of the cell, however it is not practical
to count LC densities by electron microscopy, and
any disruption of the plasma membrane which
results in loss of ATPase should render the cells
non-functional and alter their antigen trapping and
presentation capabilities. Following exposure of
mouse skin to UV-light, Aberer et al. (1981) found
LC to be present by electron microscopy, although
they were damaged and lacking in ATPase. In
contrast Noonan et al. (1984) reported UV-light to
deplete LC on both electron microscopy and
ATPase staining criteria.
Glucocorticoid-mediated loss of ATPase from the
LC membrane has been observed to require 7 days
for the ATPase to be re-expressed on the LC
membrane (Belsito et al., 1984). In our experiments,
the DMBA-treated LC-ATPase did not return to
control values until 55-64 days following cessation
of DMBA treatment. Considering this long
recovery time, it is likely that DMBA depletes LC
from the epidermis, and that the ATPase-positive
cells which reappear in the epidermis following
treatment are LC repopulating the epidermis rather
than the original population re-expressing lost
surface membrane ATPase. LC may repopulate the
epidermis either from bone marrow precursors or
from mitosis of residual LC. The time period
required for the ATPase-positive cells to repopulate
the epidermis is similar to the time required for
donor bone marrow precursors to replace epidermal
LC in chimeric mice (Tamaki & Katz, 1980).
Repeated stripping of skin with adhesive tape, and
dinitrochlorobenzene, both increase tritiated
thymidine uptake in guinea pig LC, and although
this may be due to proliferation of LC, it could
also be due to increased DNA turnover during
recovery of damaged LC (Gschnait & Brenner,
1979), particularly as mitosis of LC has only been
observed on a few occasions (Rowden, 1981). Thus
we concluded that the majority of the repopulated
LC probably arose from bone-marrow precursors
rather than from mitosis of residual LC. These
experiments do not determine whether DMBA
destroys the LC or causes it to leave the epidermis.
DMBA is known to depress natural killer cell
activity (Kalland & Forsberg, 1983), thus inhibiting
an immune effector mechanism against the tumour.
DMBA has also been shown to react with deoxy-
adenosine in the DNA of mouse skin, indicating
that its tumour inducing activity may be caused by
a direct effect on DNA (Bigger et al., 1983; Dipple
et al., 1983). However, our results suggest that as
well as acting as a tumour inducer, DMBA also
impairs immune surveillance by depleting epidermal
antigen-presenting cells. This carcinogen-induced
loss of LC may thus eliminate the potential for an
immune response to develop against the
transformed squamous cells, allowing these cells to
proliferate.
It is also possible that the depletion of LC could
result in the development of tumour-specific
immunosuppression. Ptak et al. (1980) found that
antigen coupled to epidermal cells induced
immunity when injected intravenously, whereas
antigen coupled to peritoneal exudate cells induced
specific immunological unresponsiveness. It is
possible that in the absence of LC, tumour antigens
may filter through the skin and be presented to
lymphocytes by monocytes, resulting in
unresponsiveness. Further support for this comes
from experiments by Toews et al. (1980), who
reported that antigen applied to skin depleted
of LC by UV-light resulted in specific un-
responsiveness. However, Noonan et al. (1984),
by using different wavelengths of UV-light claim
that the UV-induced loss of LC is not responsible
for the UV-induced systemic suppression; this
requires further investigation.
The reduction in tumour size observed as the LC
migrated back into the epidermis also suggests that
the LC may be involved in an immune response
against the tumours. However the mechanism of
tumour regression has not been investigated, and its
relationship with LC repopulation may be
coincidental.
Finally, whether this DMBA-induced depletion
of antigen-presenting cells is a general phenomenon
associated with the induction of all tumours will
only be apparent when the effects of other
carcinogens are examined on other antigen-
presenting cells in different regions of the body.
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